Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Identifying HIV-1 envelope (Env) traits associated with neutralization cross-reactivity is crucial for vaccine design. Variable loops 1 and 2 (V1V2), positioned at the Env trimer apex, are key regions linked to neutralization. We describe non-canonical cysteine (Cys) residues in V1 that are enriched in individuals with elite neutralization breadth. Analyzing over 65,000 V1 sequences from the CATNAP database, AMP trials, and longitudinal HIV-1 cohorts (SHCS, ZPHI, and CAPRISA), we found that Env variants with extra V1 Cys are present at low levels and fluctuate over time. Extra V1 Cys associate with elite plasma neutralization, and two additional Cys are preferred, suggesting stabilization through disulfide bonds. Among 34 broadly neutralizing antibody (bnAb)-inducer Envs, 17.6% had elongated V1 regions with extra Cys. These extra Cys moderately increased neutralization resistance and altered bnAb epitope accessibility. Collectively, altering epitope exposure alongside Env stabilization renders the V1 twin Cys motif a promising feature for HIV-1 bnAb immunogens.

Authors

Institutions

Publication Details

Journal
Cell Host & Microbe
Published
2025-02-01
DOI
https://doi.org/10.1016/j.chom.2025.01.004
Citations
2
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
2.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Nyaradzo Mgodi, Peter Rusert, Michal Juraska, Nigel Garrett et al.
2 citations
Cell Host & Microbe
HIV Research and Treatment
2.07
article

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Nyaradzo Mgodi, Peter Rusert, Michal Juraska, Nigel Garrett, Nikolas Friedrich, Michèle Sickmann, Ian Pichler, Srilatha Edupuganti, Samuel Mundia Kariuki, Marius Zeeb, Sabine Yerly, Karoline Leuzinger, Dylan H. Westfall, James I. Mullins, Penny L. Moore, Allan C. deCamp, Herbert Kuster, Matthieu Perreau, Carolyn E. Williamson, Hugh Murrell, Karin J. Metzner, Kshitij Wagh, Craig Adams, Chloé Pasin, Huldrych F. Günthard, Alexandra Trkola, Daniel Schmidt, Maria C. Hesselman, Michael Huber, Audrey Rindler, Roger D. Kouyos, Ruwayhida Thebus, Wenjie Deng, Roger Koller, Simona Frigerio, Jennifer Mamrosh, G Dollenmaier, Masako M. Kaufmann
article en
2 citations

Abstract

Identifying HIV-1 envelope (Env) traits associated with neutralization cross-reactivity is crucial for vaccine design. Variable loops 1 and 2 (V1V2), positioned at the Env trimer apex, are key regions linked to neutralization. We describe non-canonical cysteine (Cys) residues in V1 that are enriched in individuals with elite neutralization breadth. Analyzing over 65,000 V1 sequences from the CATNAP database, AMP trials, and longitudinal HIV-1 cohorts (SHCS, ZPHI, and CAPRISA), we found that Env variants with extra V1 Cys are present at low levels and fluctuate over time. Extra V1 Cys associate with elite plasma neutralization, and two additional Cys are preferred, suggesting stabilization through disulfide bonds. Among 34 broadly neutralizing antibody (bnAb)-inducer Envs, 17.6% had elongated V1 regions with extra Cys. These extra Cys moderately increased neutralization resistance and altered bnAb epitope accessibility. Collectively, altering epitope exposure alongside Env stabilization renders the V1 twin Cys motif a promising feature for HIV-1 bnAb immunogens.

Cell Host & MicrobeVol. 33(2)
National Health Laboratory Service (ZA), University of Bern (CH), Los Alamos National Laboratory (US), Emory University (US), University of Washington (US), University of Zurich (CH), University of St.Gallen (CH), University of Eldoret (KE), Centre for the AIDS Programme of Research in South Africa (ZA), University Hospital of Basel (CH), Fred Hutch Cancer Center (US), Ente Ospedaliero Cantonale (CH), University Hospital of Zurich (CH), University Hospital of Geneva (CH), University of Zimbabwe-University of California San Francisco (ZW), Institute of Virology of the Slovak Academy of Sciences (SK), University of Lausanne (CH)
National Science Foundation, Bill and Melinda Gates Foundation, Novartis Foundation, National Research Foundation, South African Medical Research Council, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Consiglio Nazionale delle Ricerche, Novartis Stiftung für Medizinisch-Biologische Forschung, Universität Zürich, National Institutes of Health, Medical Research Council
Zero hunger
Openalex Percentile: Top 16%
HIV Research and Treatment
2.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.